RTHP-10. IMPACT OF COMBINATION IMMUNOTHERAPY WITH TUMOR TREATING FIELDS THERAPY IN A GLIOMA COHORT

Jessica Schulte; Yazmin Odia; Laura Donovan; Fabio Iwamoto

doi:10.1093/neuonc/nox168.895

RTHP-10. IMPACT OF COMBINATION IMMUNOTHERAPY WITH TUMOR TREATING FIELDS THERAPY IN A GLIOMA COHORT

Jessica Schulte
, Yazmin Odia
, Laura Donovan
, Fabio Iwamoto

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Neuro-oncology
Volume	19
DOIs	https://doi.org/10.1093/neuonc/nox168.895
State	Published - Nov 6 2017

Disciplines

Medicine and Health Sciences
Immunology and Infectious Disease

Access to Document

10.1093/neuonc/nox168.895License: Unspecified

Cite this

@article{aa777df114d54be3b924b02431bc14b3,

title = "RTHP-10. IMPACT OF COMBINATION IMMUNOTHERAPY WITH TUMOR TREATING FIELDS THERAPY IN A GLIOMA COHORT",

author = "Jessica Schulte and Yazmin Odia and Laura Donovan and Fabio Iwamoto",

note = "Tumor-treating fields (TTF) increase patient survival in glioblastoma, and are approved for recurrent (2011) and de novotumors (2016). Since 2012, 52 patients with gliomas at Columbia University were treated with TTF. Given preclinical data suggesting synergy between TTF and PD1-targeted therapy, the rates and outcomes of combination TTF and immunotherapy were analyzed.",

year = "2017",

month = nov,

day = "6",

doi = "10.1093/neuonc/nox168.895",

language = "American English",

volume = "19",

journal = "Neuro-oncology",

}

TY - JOUR

T1 - RTHP-10. IMPACT OF COMBINATION IMMUNOTHERAPY WITH TUMOR TREATING FIELDS THERAPY IN A GLIOMA COHORT

AU - Schulte, Jessica

AU - Odia, Yazmin

AU - Donovan, Laura

AU - Iwamoto, Fabio

N1 - Tumor-treating fields (TTF) increase patient survival in glioblastoma, and are approved for recurrent (2011) and de novotumors (2016). Since 2012, 52 patients with gliomas at Columbia University were treated with TTF. Given preclinical data suggesting synergy between TTF and PD1-targeted therapy, the rates and outcomes of combination TTF and immunotherapy were analyzed.

PY - 2017/11/6

Y1 - 2017/11/6

UR - http://academic.oup.com/neuro-oncology/article/19/suppl_6/vi221/4591320

U2 - 10.1093/neuonc/nox168.895

DO - 10.1093/neuonc/nox168.895

M3 - Article

VL - 19

JO - Neuro-oncology

JF - Neuro-oncology

ER -

RTHP-10. IMPACT OF COMBINATION IMMUNOTHERAPY WITH TUMOR TREATING FIELDS THERAPY IN A GLIOMA COHORT

Disciplines

Access to Document

Other files and links

Cite this